Article Details

Cognito Therapeutics completes enrollment in landmark Alzheimer's trial

Retrieved on: 2025-07-01 15:03:13

Tags for this article:

Click the tags to see associated articles and topics

Cognito Therapeutics completes enrollment in landmark Alzheimer's trial. View article details on hiswai:

Excerpt

73% of patients had rheumatic heart disease, a condition prevalent in developing regions. Read more. Medical TechnologyEmerging TechnologyMedical ...

Article found on: www.medicaleconomics.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo